Product
CAR.70/IL15-transduced CB-derived NK cells
1 clinical trial
3 indications
Indication
Renal Cell CarcinomaIndication
Advanced MesotheliomaIndication
OsteosarcomaClinical trial
Phase I/II Study of CAR.70-engineered IL15-transduced Cord Blood-derived NK Cells in Conjunction With Lymphodepleting Chemotherapy for the Management of Advanced Renal Cell Carcinoma, Mesothelioma and OsteosarcomaStatus: Recruiting, Estimated PCD: 2025-09-30